Key terms

About RLAY

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest RLAY news

Mar 19 1:38am ET Strong Buy Rating for Relay Therapeutics Amid Pipeline Progress and Strategic Direction by TipRanks Feb 27 6:46am ET Relay Therapeutics price target lowered to $25 from $27 at BofA by TipRanks Feb 27 12:30am ET Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Relay Therapeutics (RLAY) and Regeneron (REGN) by TipRanks Feb 26 6:18am ET Relay Therapeutics: Strong Buy on Improved Financials and Promising Future Milestones by TipRanks Feb 26 6:10am ET Relay Therapeutics price target raised to $20 from $17 at H.C. Wainwright by TipRanks Feb 23 3:05am ET Relay Therapeutics (RLAY) Gets a Hold from Barclays by TipRanks Feb 22 6:35pm ET Optimistic Buy Rating for Relay Therapeutics: Strong Financial Standing and Strategic Pipeline Focus by TipRanks Feb 22 4:30pm ET Relay Therapeutics reports Q 4 EPS (67c), consensus (75c) by TipRanks Feb 22 9:06am ET Relay Therapeutics price target raised to $30 from $25 at Stifel by TipRanks Feb 15 1:17am ET Relay Therapeutics Poised for Growth with Promising RLY-2608, Analyst Maintains Buy Rating by TipRanks Jan 22 1:10pm ET Analysts Offer Insights on Healthcare Companies: Kinnate Biopharma (KNTE), Relay Therapeutics (RLAY) and Eyenovia (EYEN) by TipRanks Jan 18 5:37am ET Bank of America Says These 3 Healthcare Stocks Have up to ~160% Upside Potential by TipRanks Jan 08 8:02am ET Relay Therapeutics to sell 2.5M shares at $12.00 in private placement by TipRanks
Mar 14 10:00am ET Kuehn Law Encourages Investors of Relay Therapeutics, Inc. to Contact Law Firm by Newsfile

RLAY Financials

1-year income & revenue

Key terms

RLAY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

RLAY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days